Drug Safety in Clinical Trials in Colombia

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0

Sites Throughout LATAM

+ 200

Patients in our network

+ 0

Conducted Studies

0 %

Lost-to-Follow Up rate

As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Drug Safety in Clinical Trials in Colombia

Drug Safety in Clinical Trials in Colombia – Cohortias the CRO of LATAM

Clinical trials serve as a crucial gateway to advancing medical knowledge and introducing innovative treatments to patients. Safeguarding participant well-being and ensuring drug safety are paramount during these trials. In Colombia, a well-regulated clinical trial environment exists to protect participants and maintain the highest ethical standards.

This blog post will provide an in-depth exploration of drug safety in clinical trials in Colombia, including the regulatory framework, ethical considerations, monitoring mechanisms, and collaborative efforts among stakeholders.

Regulatory Framework and Oversight

Colombia has established a robust regulatory framework for the oversight of clinical trials to ensure drug safety. The regulatory authority responsible for this oversight is the National Food and Drug Surveillance Institute (INVIMA). INVIMA ensures that clinical trials comply with ethical principles, follow international guidelines, and evaluate the risks and benefits associated with investigational drugs.

Clinical trials conducted in Colombia undergo a rigorous review process, including approval from an ethics committee and authorization from INVIMA. The ethics committee evaluates key aspects such as study design, participant selection criteria, informed consent procedures, and safety monitoring plans. By adhering to stringent regulations and oversight mechanisms, Colombia maintains a high standard of drug safety in clinical trials.

Ethical Considerations and Informed Consent

Ethical considerations are at the core of clinical trials in Colombia. The principles of autonomy, beneficence, and justice guide the ethical decision-making process. Ensuring informed consent is a crucial aspect of protecting participants’ rights and promoting drug safety.

Informed consent in Colombia requires providing comprehensive information to participants in a language they understand. This includes details about the investigational drug, study procedures, potential risks, benefits, and alternatives. Participants should have sufficient time to ask questions and make an informed decision about their participation in the trial.

Drug Safety in Clinical Trials in Colombia

Drug Safety in Clinical Trials in Colombia

Monitoring and Pharmacovigilance

Monitoring and pharmacovigilance mechanisms play a vital role in maintaining drug safety throughout clinical trials in Colombia. INVIMA requires investigators to implement robust safety monitoring plans to promptly detect and manage adverse events or unexpected reactions.

Monitoring activities include regular inspections of clinical trial sites by regulatory authorities, ensuring compliance with protocols, good clinical practices (GCP), and ethical guidelines. These inspections help identify any deviations from approved protocols, ensuring the safety and integrity of the trials.

Pharmacovigilance, the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems, is also crucial in drug safety during clinical trials. Investigators and sponsors have an obligation to report all adverse events to INVIMA within specified timelines. INVIMA collaborates with international agencies and experts to evaluate the reported data and take necessary actions to protect participant safety.

Collaboration and Future Perspectives

Ensuring drug safety in clinical trials requires collaboration among stakeholders, including researchers, ethics committees, regulatory authorities, and sponsors. In Colombia, efforts to strengthen these collaborations, promote transparency, and protect participant rights are ongoing.

Looking ahead, Colombia aims to further enhance drug safety in clinical trials by harnessing emerging technologies and fostering international collaborations. The adoption of electronic data capture, real-time monitoring systems, and advanced analytics can streamline safety reporting and signal detection, leading to more efficient risk management.

Conclusion

Colombia maintains a stringent regulatory framework and ethical guidelines to prioritize drug safety in clinical trials. With the active participation of regulatory authorities, ethics committees, and stakeholders, Colombia ensures that trials are conducted with utmost care, protecting the well-being of participants. By continuing to embrace advancements in technology and fostering international collaborations, Colombia is well-positioned to further enhance drug safety in clinical trials and contribute to the advancement of medical research.

Drug Safety in Clinical Trials in Colombia

Source: Pro Colombia

Welcome to Cohortias!

The CRO
of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Drug Safety in Clinical Trials in Colombia

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.

Drug Safety in Clinical Trials in Colombia

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Drug Safety in Clinical Trials in Colombia

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Drug Safety in Clinical Trials in Colombia

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.

CLINICAL DEVELOPMENT

Site Management

Data Management

Site Selection

Regulatory Submissions

Clinical Monitoring

Protocol Development

CLINICAL TRIAL SERVICES

Beta Trials Platform

First-in-human studies

Medical Devices

Pilot and Pivotal Device Studies

Phases I – III

We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards

MAIN THERAPEUTIC AREAS

Diabetes/Metabolic Syndromes
Infectious Diseases
Cardiovascular
Neurology
Respiratory
Oncology

Drug Safety in Clinical Trials in Colombia

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

We offer the quickest start-up times in each country.
Efficient Clinical Site Selection and Contracting.
Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

Proven record of delivering rescue studies, we consistently exceed industry performance standards.
Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
At Cohortias, we prioritize short lines of communication to ensure efficient collaboration.
Swift adaptation to changes in the trial landscape to keep your study on schedule.

Drug Safety in Clinical Trials in Colombia

We provide our services with offices in:

Argentina,
Brazil,
Colombia &
Mexico.

Drug Safety in Clinical Trials in Colombia

The Cohortias Team

Drug Safety in Clinical Trials in Colombia

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Drug Safety in Clinical Trials in Colombia

Network & Partnerships

CROs alliance of Mexico

Health System of Tec de Monterrey

The Science CRO of Europe